(Q33569145)

28 July 2017

title

Modeling screening, prevention, and delaying of Alzheimer's disease: an early-stage decision analytic model (English)

1 reference

28 July 2017

0 references

Nicolas M Furiak

1

1 reference

28 July 2017

Robert W Klein

2

1 reference

28 July 2017

Kristin Kahle-Wrobleski

3

1 reference

28 July 2017

Eric R Siemers

4

1 reference

28 July 2017

Eric Sarpong

5

1 reference

28 July 2017

Timothy M Klein

6

1 reference

28 July 2017

publication date

30 April 2010

1 reference

BMC Medical Informatics and Decision Making

28 July 2017

published in

1 reference

28 July 2017

volume

10

1 reference

28 July 2017

page(s)

24

1 reference

Creative Commons Attribution 2.0 Generic

28 July 2017

copyright license

start time

30 April 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Mortality results from a randomized prostate-cancer screening trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152764

Functional and cognitive criteria produce different rates of mild cognitive impairment and conversion to dementia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152764

How does age affect baseline screening mammography performance measures? A decision model

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152764

Amyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: a review of recent literature

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152764

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152764

Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152764

Diagnostic criteria of dementia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152764

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152764

Toward optimal screening strategies for older women. Costs, benefits, and harms of breast cancer screening by age, biology, and health status.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152764

Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152764

Mild cognitive impairment as a diagnostic entity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152764

Alzheimer Disease in the US Population

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152764

Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152764

Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152764

Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152764

US women's attitudes to false-positive mammography results and detection of ductal carcinoma in situ: cross-sectional survey

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152764

Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152764

Serial prostate specific antigen screening for prostate cancer: a computer model evaluates competing strategies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152764

Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6947-10-24

Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6947-10-24

Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6947-10-24

Endoscopic requirements of colorectal cancer screening programs in average-risk population. Estimation according to a Markov model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6947-10-24

HCV screening to enable early treatment of hepatitis C: a mathematical model to analyse costs and outcomes in two populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6947-10-24

Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6947-10-24

Early discontinuation of tamoxifen: a lesson for oncologists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6947-10-24

Drug persistency of two cholinesterase inhibitors: rivastigmine versus donepezil in elderly patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6947-10-24

The cost-effectiveness of donepezil therapy in Swedish patients with Alzheimer's disease: a Markov model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6947-10-24

Economic evaluation of donepezil for the treatment of Alzheimer's disease in Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6947-10-24

A cost-effectiveness analysis of cervical cancer screening: health policy implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6947-10-24

Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152764

Drug persistency patterns for patients treated with rivastigmine or donepezil in usual care settings

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3152764

Economic evaluation of a prostate cancer screening program in France: a decision model

31 October 2018

1 reference

12 December 2020

Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages

1 reference

12 December 2020

Pharmacotherapy for people with Alzheimer's disease: a Markov-cycle evaluation of five years' therapy using donepezil

1 reference

12 December 2020

Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease

1 reference

12 December 2020

Persistence with treatment in newly treated middle-aged patients with essential hypertension

1 reference

12 December 2020

Identifiers

DOI

10.1186/1472-6947-10-24

1 reference

journals/midm/FuriakKKSSK10

28 July 2017

DBLP publication ID

1 reference

DBLP Dataset 2021-01-02

Dimensions Publication ID

28 January 2021

0 references

1 reference

28 July 2017

1 reference